Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Chaperone switching at the kinase CDK5 mediates epigenetic effects of antidepressants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Stress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
The complex language of chromatin regulation during transcription
Berger, S. L. (2007) · Nature · doi:10.1038/nature05915 · Cited by 2,768 · cited 1×
“SC is largely confined to CpG dinucleotides in the mammalian genome and is executed byDNAmethyltransferases (DNMTs) (4), which comprise a family of proteins with three subtypes that exhibit different specificities and functions: DNMT1, DNMT3a, and DNMT3b (5).”
BackgroundHuber, W., von Heydebreck, A., Sültmann, H., Poustka, A., & Vingron, M. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.suppl_1.s96 · Cited by 2,440
Hsp90 as a capacitor for morphological evolution
Rutherford, S. L., & Lindquist, S. (1998) · Nature · doi:10.1038/24550 · Cited by 2,270
Du, P., Zhang, X., Huang, C.-C., Jafari, N., Kibbe, W. A., Hou, L., & Lin, S. M. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-587 · Cited by 2,136
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780 · cited 1×
“To date, the Bdnf promoter of exon IV (called promoter IV) is one of the best characterized (9, 45, 46).”
BackgroundAllele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions
Klengel, T., Mehta, D., Anacker, C., Rex-Haffner, M., Pruessner, J. C., Pariante, C. M., Pace, T. W. W., Mercer, K. B., Mayberg, H. S., Bradley, B., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3275 · Cited by 1,447
Self-citationDNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation
Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G., & Sun, Y. E. (2003) · Science · doi:10.1126/science.1090842 · Cited by 1,405
Binder, E. B. (2008) · JAMA · doi:10.1001/jama.299.11.1291 · Cited by 1,362
Self-citation
Cited by
Molecular pathways of major depressive disorder converge on the synapse
Fries, G. R., Saldana, V. A., Finnstein, J., & Rein, T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01806-1 · Cited by 504
“FKBP51 is intertwined with other pathways related to depression: it is a target of epigenetic programming [100, 101], but potentially also a sculptor of the epigenetic landscape through its action on DNA methyltransferase 1 [102].”
BackgroundSelf-citationGassen, N. C., Niemeyer, D., Muth, D., Corman, V. M., Martinelli, S., Gassen, A., Hafner, K., Papies, J., Mösbauer, K., Zellner, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13659-4 · Cited by 356
Self-citationMatosin, N., Halldorsdottir, T., & Binder, E. B. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.021 · Cited by 226
Self-citationEpigenetic programming by stress and glucocorticoids along the human lifespan
Zannas, A. S., & Chrousos, G. P. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.35 · Cited by 158
Self-citationHing, B., Sathyaputri, L., & Potash, J. B. (2018) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32616 · Cited by 137
“increased Bdnf exon IV expression (Dwivedi & Zhang, 2014; Gassen et al., 2015).”
BackgroundHähle, A., Merz, S., Meyners, C., & Hausch, F. (2019) · Biomolecules · doi:10.3390/biom9010035 · Cited by 119
“For CDKs, an antagonizing action mode of FKBP51 and 52 was described for their respective impact on DNA methylation [95].”
BackgroundInfluentialBlood biomarkers and treatment response in major depression
Mora, C., Zonca, V., Riva, M. A., & Cattaneo, A. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1470927 · Cited by 107
“depressed patients with the antidepressant paroxetine and they found that the treatment increased BDNF expression, an effect that was due to reduced activity of DNMT1 and DNA methylation [68].”
BackgroundFKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression
Ising, M., Maccarrone, G., Brückl, T., Scheuer, S., Hennings, J., Holsboer, F., Turck, C. W., Uhr, M., & Lucae, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030485 · Cited by 60
“These pathways include the glycogen synthase kinase-3 (GSK-3) beta pathway [32], autophagy [33], and the modulation of enzymes of the epigenetic machinery [34].”
Self-citationSales, A. J., Guimarães, F. S., & Joca, S. R. L. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112627 · Cited by 58
Clayton, D. F., Anreiter, I., Aristizabal, M., Frankland, P. W., Binder, E. B., & Citri, A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820837116 · Cited by 56
Self-citationSales, A. J., & Joca, S. R. L. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.01.022 · Cited by 47
The importance of epigenetics in diagnostics and treatment of major depressive disorder
Czarny, P., Białek, K., Ziółkowska, S., Strycharz, J., Barszczewska, G., & Sliwinski, T. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030167 · Cited by 37
Moving pharmacoepigenetics tools for depression toward clinical use
Hack, L. M., Fries, G. R., Eyre, H. A., Bousman, C. A., Singh, A. B., Quevedo, J., John, V. P., Baune, B. T., & Dunlop, B. W. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.02.009 · Cited by 33
“In a human study, researchers demonstrated a significant association between clinical response to paroxetine after 6 weeks of treatment in MDD patients and phosphorylation of DNMT1 in isolated peripheral blood mononuclear cells from the same patients (Gassen et al., 2015).”
BackgroundSelf-citationAnderzhanova, E., Hafner, K., Genewsky, A. J., Soliman, A., Pöhlmann, M. L., Schmidt, M. V., Blum, R., Wotjak, C. T., & Gassen, N. C. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100239 · Cited by 29
Self-citationMohammadi, S., Beh-Pajooh, A., Ahmadimanesh, M., Amini, M., Ghazi-Khansari, M., Moallem, S. A., Hosseini, R., Nourian, Y. H., & Ghahremani, M. H. (2022) · Epigenomics · doi:10.2217/epi-2022-0246 · Cited by 23
Tricyclic antidepressants target FKBP51 SUMOylation to restore glucocorticoid receptor activity
Budziñski, M. L., Sokn, C., Gobbini, R., Ugo, B., Antunica-Noguerol, M., Senin, S., Bajaj, T., Gassen, N. C., Rein, T., Schmidt, M. V., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01491-0 · Cited by 17
Self-citation
Metadata
- Authors
- Gassen, N. C., Fries, G. R., Zannas, A. S., Hartmann, J., Zschocke, J., Hafner, K., Carrillo-Roa, T., Steinbacher, J., Preißinger, S. N., Hoeijmakers, L., Knop, M., Weber, F., Kloiber, S., Lucae, S., Chrousos, G. P., Carell, T., Ising, M., Binder, E. B., Schmidt, M. V., Rüegg, J., & Rein, T.
- Venue
- Science Signaling
- Published
- 2015-11-24
- Volume
- 8
- Issue
- 404
- Pages
- ra119-ra119
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- OpenAlex
- W2178008393
- Cited by
- 107
- References
- 44
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.